Safeguard Financial’s Gilead Sciences GILD Stock Holding History

Safeguard Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-222	Closed	-$17K	–	252
2023 Q2	$17K	Buy	+222	New	+$17.7K	0.01%	283

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Safeguard Financial's GILD Position: Q3 2023 in Review

Safeguard Financial sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 222 shares — an estimated $17K sold.

Safeguard Financial first reported a position in GILD in Q2 2023 and held it in 1 quarter. The position peaked at $17K in Q2 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Safeguard Financial reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Safeguard Financial sold 222 Gilead Sciences shares in Q3 2023, an estimated $17K.
Safeguard Financial first reported a position in Gilead Sciences in Q2 2023 and held it in 1 quarter.
Safeguard Financial's Gilead Sciences position peaked at $17K in Q2 2023.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Safeguard Financial's 13F filing for Q3 2023, filed 30 Oct 2023.